Analyst Reco. iNtRON Biotechnology, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 09/06/2024 BST			5-day change	1st Jan Change
5,950 ^KRW	-3.09%		-4.49%	-32.23%

03-13	INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-15	Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer	CI

No results for this search